Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
May 15, 2009

Odyssey Thera to Help Mitsubishi Tanabe Pharma with Preclinical Research

  • Odyssey Thera will analyze drug candidates from a number of preclinical programs for Mitsubishi Tanabe Pharma. Odyssey Thera will apply its patented protein-fragment complementation assay, high-context screening infrastructure, institutional knowledge, and data analysis strategies in the collaboration to yield insights related to drug selectivity, safety, and mechanisms of action.

    Odyssey also reports the issuance of a Japanese patent entitled, “Protein fragment complementation assays for the detection of biological or drug interactions.”



Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »